Both genetic and pharmacologic inhibition of early stage autophagy, particularly in the presence of BRAFi, reduced tumor cell growth and enhanced tumor cell death in BRAF mutant CNS tumor cells irrespective of their RAFi sensitivity. Here, BRAF is linked to central nervous system neoplasm.